Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

SELL
$2.65 - $3.81 $3,908 - $5,619
-1,475 Reduced 22.39%
5,112 $15,000
Q4 2022

Jan 23, 2023

SELL
$3.38 - $4.22 $486 - $607
-144 Reduced 2.14%
6,587 $0
Q2 2022

Jul 25, 2022

SELL
$4.41 - $5.69 $158,147 - $204,049
-35,861 Reduced 84.2%
6,731 $35,000
Q1 2022

May 02, 2022

BUY
$4.81 - $6.99 $12,366 - $17,971
2,571 Added 6.42%
42,592 $233,000
Q4 2021

Jan 28, 2022

BUY
$5.97 - $7.93 $238,925 - $317,366
40,021 New
40,021 $272,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.